Selected research
Market Structure
Global Lipids in Human Nutrition Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Lipids in Human Nutrition market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Lipids in Human Nutrition is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Lipids in Human Nutrition is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Lipids in Human Nutrition is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Lipids in Human Nutrition is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Lipids in Human Nutrition include DSM, Polaris, ADM, BASF, FMC Corporation, Lonza Group AG, Omega Protein Corporation and Cargill, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Lipids in Human Nutrition market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Lipids in Human Nutrition and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Lipids in Human Nutrition sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Lipids in Human Nutrition market size, projected growth trends, production technologies, key applications, and end-use industries.
Lipids in Human Nutrition Segment by Company
DSM
Polaris
ADM
BASF
FMC Corporation
Lonza Group AG
Omega Protein Corporation
Cargill
Lipids in Human Nutrition Segment by Type
Triglycerides
Phospholipids
Other
Lipids in Human Nutrition Segment by Application
Dietary Supplements
Functional Nutrition
Sports Nutrition
Baby Nutrition
Other
Lipids in Human Nutrition Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lipids in Human Nutrition market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Lipids in Human Nutrition and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lipids in Human Nutrition.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Lipids in Human Nutrition market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Lipids in Human Nutrition manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Lipids in Human Nutrition in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Lipids in Human Nutrition in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Triglycerides
- Phospholipids
- Other
Applications
- Dietary Supplements
- Functional Nutrition
- Sports Nutrition
- Baby Nutrition
- Other
Companies covered
- DSM
- Polaris
- ADM
- BASF
- FMC Corporation
- Lonza Group AG
- Omega Protein Corporation
- Cargill
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Lipids in Human Nutrition Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Lipids in Human Nutrition Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Lipids in Human Nutrition Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Lipids in Human Nutrition Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Lipids in Human Nutrition Market Dynamics
- 2.1 Lipids in Human Nutrition Industry Trends
- 2.2 Lipids in Human Nutrition Industry Drivers
- 2.3 Lipids in Human Nutrition Industry Opportunities and Challenges
- 2.4 Lipids in Human Nutrition Industry Restraints
3 Lipids in Human Nutrition Market by Manufacturers
- 3.1 Global Lipids in Human Nutrition Revenue by Manufacturers (2021-2026)
- 3.2 Global Lipids in Human Nutrition Sales by Manufacturers (2021-2026)
- 3.3 Global Lipids in Human Nutrition Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Lipids in Human Nutrition Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Lipids in Human Nutrition Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Lipids in Human Nutrition Manufacturers, Product Type & Application
- 3.7 Global Lipids in Human Nutrition Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Lipids in Human Nutrition Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Lipids in Human Nutrition Players Market Share by Revenue in 2025
- 3.8.3 2025 Lipids in Human Nutrition Tier 1, Tier 2, and Tier 3
4 Lipids in Human Nutrition Market by Type
- 4.1 Lipids in Human Nutrition Type Introduction
- 4.1.1 Triglycerides
- 4.1.2 Phospholipids
- 4.1.3 Other
- 4.2 Global Lipids in Human Nutrition Sales by Type
- 4.2.1 Global Lipids in Human Nutrition Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Lipids in Human Nutrition Sales by Type (2021-2032)
- 4.2.3 Global Lipids in Human Nutrition Sales Market Share by Type (2021-2032)
- 4.3 Global Lipids in Human Nutrition Revenue by Type
- 4.3.1 Global Lipids in Human Nutrition Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Lipids in Human Nutrition Revenue by Type (2021-2032)
- 4.3.3 Global Lipids in Human Nutrition Revenue Market Share by Type (2021-2032)
5 Lipids in Human Nutrition Market by Application
- 5.1 Lipids in Human Nutrition Application Introduction
- 5.1.1 Dietary Supplements
- 5.1.2 Functional Nutrition
- 5.1.3 Sports Nutrition
- 5.1.4 Baby Nutrition
- 5.1.5 Other
- 5.2 Global Lipids in Human Nutrition Sales by Application
- 5.2.1 Global Lipids in Human Nutrition Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Lipids in Human Nutrition Sales by Application (2021-2032)
- 5.2.3 Global Lipids in Human Nutrition Sales Market Share by Application (2021-2032)
- 5.3 Global Lipids in Human Nutrition Revenue by Application
- 5.3.1 Global Lipids in Human Nutrition Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Lipids in Human Nutrition Revenue by Application (2021-2032)
- 5.3.3 Global Lipids in Human Nutrition Revenue Market Share by Application (2021-2032)
6 Global Lipids in Human Nutrition Sales by Region
- 6.1 Global Lipids in Human Nutrition Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Lipids in Human Nutrition Sales by Region (2021-2032)
- 6.2.1 Global Lipids in Human Nutrition Sales by Region (2021-2026)
- 6.2.2 Global Lipids in Human Nutrition Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Lipids in Human Nutrition Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Lipids in Human Nutrition Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Lipids in Human Nutrition Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Lipids in Human Nutrition Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Lipids in Human Nutrition Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Lipids in Human Nutrition Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Lipids in Human Nutrition Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Lipids in Human Nutrition Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Lipids in Human Nutrition Revenue by Region
- 7.1 Global Lipids in Human Nutrition Revenue by Region
- 7.1.1 Global Lipids in Human Nutrition Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Lipids in Human Nutrition Revenue by Region (2021-2026)
- 7.1.3 Global Lipids in Human Nutrition Revenue by Region (2027-2032)
- 7.1.4 Global Lipids in Human Nutrition Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Lipids in Human Nutrition Revenue (2021-2032)
- 7.2.2 North America Lipids in Human Nutrition Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Lipids in Human Nutrition Revenue (2021-2032)
- 7.3.2 Europe Lipids in Human Nutrition Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Lipids in Human Nutrition Revenue (2021-2032)
- 7.4.2 Asia-Pacific Lipids in Human Nutrition Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Lipids in Human Nutrition Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Lipids in Human Nutrition Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 DSM
- 8.1.1 DSM Company Information
- 8.1.2 DSM Business Overview
- 8.1.3 DSM Lipids in Human Nutrition Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 DSM Lipids in Human Nutrition Product Portfolio
- 8.1.5 DSM Recent Developments
- 8.2 Polaris
- 8.2.1 Polaris Company Information
- 8.2.2 Polaris Business Overview
- 8.2.3 Polaris Lipids in Human Nutrition Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Polaris Lipids in Human Nutrition Product Portfolio
- 8.2.5 Polaris Recent Developments
- 8.3 ADM
- 8.3.1 ADM Company Information
- 8.3.2 ADM Business Overview
- 8.3.3 ADM Lipids in Human Nutrition Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 ADM Lipids in Human Nutrition Product Portfolio
- 8.3.5 ADM Recent Developments
- 8.4 BASF
- 8.4.1 BASF Company Information
- 8.4.2 BASF Business Overview
- 8.4.3 BASF Lipids in Human Nutrition Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 BASF Lipids in Human Nutrition Product Portfolio
- 8.4.5 BASF Recent Developments
- 8.5 FMC Corporation
- 8.5.1 FMC Corporation Company Information
- 8.5.2 FMC Corporation Business Overview
- 8.5.3 FMC Corporation Lipids in Human Nutrition Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 FMC Corporation Lipids in Human Nutrition Product Portfolio
- 8.5.5 FMC Corporation Recent Developments
- 8.6 Lonza Group AG
- 8.6.1 Lonza Group AG Company Information
- 8.6.2 Lonza Group AG Business Overview
- 8.6.3 Lonza Group AG Lipids in Human Nutrition Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Lonza Group AG Lipids in Human Nutrition Product Portfolio
- 8.6.5 Lonza Group AG Recent Developments
- 8.7 Omega Protein Corporation
- 8.7.1 Omega Protein Corporation Company Information
- 8.7.2 Omega Protein Corporation Business Overview
- 8.7.3 Omega Protein Corporation Lipids in Human Nutrition Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Omega Protein Corporation Lipids in Human Nutrition Product Portfolio
- 8.7.5 Omega Protein Corporation Recent Developments
- 8.8 Cargill
- 8.8.1 Cargill Company Information
- 8.8.2 Cargill Business Overview
- 8.8.3 Cargill Lipids in Human Nutrition Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Cargill Lipids in Human Nutrition Product Portfolio
- 8.8.5 Cargill Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Lipids in Human Nutrition Value Chain Analysis
- 9.1.1 Lipids in Human Nutrition Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Lipids in Human Nutrition Production Mode & Process
- 9.2 Lipids in Human Nutrition Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Lipids in Human Nutrition Distributors
- 9.2.3 Lipids in Human Nutrition Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst